Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Net Margin (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Net Margin for 3 consecutive years, with 3467.24% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 143058.0% to 3467.24% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1440.28% through Dec 2025, up 648518.0% year-over-year, with the annual reading at 1445.77% for FY2025, 649764.0% up from the prior year.
  • Net Margin hit 3467.24% in Q4 2025 for Camp4 Therapeutics, down from 1663.9% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 840.01% in Q2 2025 to a low of 3467.24% in Q4 2025.
  • Historically, Net Margin has averaged 2134.63% across 3 years, with a median of 1850.28% in 2025.
  • Biggest YoY gain for Net Margin was -143058bps in 2025; the steepest drop was -143058bps in 2025.
  • Year by year, Net Margin stood at 3341.71% in 2023, then surged by 39bps to 2036.66% in 2024, then plummeted by -70bps to 3467.24% in 2025.
  • Business Quant data shows Net Margin for CAMP at 3467.24% in Q4 2025, 1663.9% in Q3 2025, and 840.01% in Q2 2025.